Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05956093 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

68Ga-FAPI PET/CT in the Staging of High-Grade Epithelial Ovarian Cancers: A Pilot Study

Study acronym: FAST HOC
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Apr 25, 2026 → Sep 25, 2026
See other at-risk trials from University Health Network, Toronto

Record History

  1. Trial status changed: Not Yet Recruiting → Active, Not Recruiting Primary completion pushed from Apr 25, 2026 to Sep 25, 2026 · Completion pushed from May 30, 2026 to Dec 30, 2026 · Study sites: 0 to 1 · 3 more Show 6 more changesShow less
    • Primary completion pushed from Apr 25, 2026 to Sep 25, 2026
    • Completion pushed from May 30, 2026 to Dec 30, 2026
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 25, 2025 to Sep 25, 2024
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 1 of 2 entries
  2. Start date: Jun 25, 2025 to Sep 25, 2025v13
  3. Start date: May 25, 2025 to Jun 25, 2025v12
  4. Start date: Mar 24, 2025 to May 25, 2025v11
  5. Start date: Dec 24, 2024 to Mar 24, 2025v10
Show 8 earlier versionsHide 8 earlier versions
  1. Start date: Oct 25, 2024 to Dec 24, 2024v9
  2. Study Identification, Study Status, Contacts/Locations, IPDSharingv8
  3. Start date: Jul 25, 2024 to Oct 25, 2024v7
  4. Start date: May 25, 2024 to Jul 25, 2024v6
  5. Start date: Mar 25, 2024 to May 25, 2024v5
  6. Start date: Dec 10, 2023 to Mar 25, 2024v4
  7. Start date: Aug 10, 2023 to Dec 10, 2023v3
  8. Start date: Jul 12, 2023 to Aug 10, 2023 Secondary endpoints: details revised at 2 of 2 entriesv2 Show 1 more changeShow less
    • Secondary endpoints: details revised at 2 of 2 entries
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigator will use a technology called PET-CT that combines a Positron Emission Tomography (PET) scan with a computed tomography (CT) scan. This combined imaging test, where PET and CT data are gathered at one time, will be performed on an integrated PET-CT scanner located at Princess Margaret Cancer Centre. The purpose of this study is to find out if the use of 68Ga-PNT6555 (FAPI) PET-CT will improve the assessment of disease extent as compared to routine CT scans.
Trial Details
NCT Number NCT05956093
Lead Sponsor University Health Network, Toronto
Conditions High Grade Serous Ovarian Cancer (HGSOC)
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov